How EU and Global Brands Plan a US Supplement Market Entry

Adding a new EU country to an existing catalogue is largely a translation and label exercise: the underlying regulatory doctrine, currency zone and buyer expectations stay recognisably similar from one market to the next. Entering the US changes more than the label. The regulatory doctrine is different, the retail and marketplace landscape works on its own logic, and the review cadence a brand owner needs to run day to day does not map cleanly from an EU playbook. Treating a US launch as one more market on an existing rollout list is the single most common way a brand owner under-invests in the decision at the point it actually matters.

The costlier version of that mistake shows up after the concept work is already done: an EU-first label gets adapted for the US at the artwork stage, a channel plan built around EU retail habits gets applied to an unfamiliar US buyer landscape, and a pack size chosen for a European shelf turns out to be a mismatch for a US retail account or a marketplace listing. Every one of those corrections is cheaper before the brief is written than after production is scheduled, which is exactly why the sequencing question deserves its own section before any of the practical channel questions that follow.

The right order mirrors any other launch decision a brand owner makes elsewhere in this playbook: decide why you are entering the US before deciding how. A brand responding to inbound interest from a single US retailer is making a different decision than a brand choosing the US as a deliberate second growth market, and the two starting points point toward different channel plans, different timelines and a different first-year budget, even though the manufacturing route and the production doctrine underneath both is identical.

What follows sets that decision framework at the level a brand owner needs before writing a US-bound brief: the federal doctrine, the DTC-versus-retail fork, Amazon as its own channel, and what genuinely changes, and does not, in a manufacturing relationship once the US joins an existing EU or UK rollout. Label-format mechanics and channel-by-channel playbooks each deserve their own deeper treatment; the sections below are the map to read before those.

US dietary supplements sit inside a single federal framework rather than the patchwork most EU brand owners are used to navigating market by market. A brand owner does not need to become a regulatory specialist to plan a US launch, but understanding the shape of the doctrine changes how the brief gets written. Dietary supplements are regulated federally as a category of food, not cleared individually as a drug before they reach a shelf, and responsibility for a truthful, substantiated label sits with the brand bringing the product to market, not with a government pre-launch review.

That absence of a pre-market approval step is easy to misread as an absence of a regulatory question altogether. It is closer to the opposite: because there is no clearance stage checking the label before launch, the ongoing accuracy of what is printed on pack becomes the entire compliance question, not a formality a review board quietly handles for you. A brand owner planning a US entry should treat label copy, the ingredient declaration and every claim on pack as the centre of the compliance conversation, not a late-stage detail to fix once everything else is settled.

This section deliberately stays at the doctrine level rather than working through label-format mechanics — that level of detail deserves a guide of its own. The one sentence worth carrying out of this section: the operative frame for the product-regulatory question is federal, and the brand owner's compliance ownership does not shift because a contract manufacturer is doing the production. A manufacturer supports that work with documentation and an artwork review; it does not take the responsibility off the brand owner's plate.

None of this changes because a manufacturer already supports EU and UK brands moving into the US: the federal framework applies identically regardless of where a brand's other markets sit, and a brand already comfortable with EU documentation discipline frequently finds the US federal model logistically simpler to plan around, precisely because it is one framework rather than several national regimes to reconcile at once.

A frequent early mistake for an EU brand owner is importing an EU-shaped mental model of the US: assuming meaningful variability market to market the way an EU rollout sees variability country to country. For the product-regulatory question specifically, the federal framework above is the operative layer. State-level rules mostly touch adjacent business questions — how a company registers to do business, or how sales tax is collected — rather than the supplement product doctrine itself.

State-by-state detail is not covered here, and a first US entry does not need it either. The decision that matters for a first launch is federal readiness — a compliant label, a clear claims policy, a channel plan — not fifty separate state reviews run in parallel before you have sold a single unit. Treat state-level questions as an operational workstream that follows the brand and channel decisions, not a prerequisite that has to be cleared before those decisions can be made.

Brand owners who over-invest early in state-by-state research before the concept and channel plan are settled tend to slow down a decision that was actually simple: decide the brand, decide the channel, and let operational detail follow in the order it actually becomes relevant — the same sequencing discipline that applies to format choice inside any private label launch.

Once the federal picture is settled, the first channel decision is direct-to-consumer versus retail, and it shapes almost everything that follows: pack design, first production quantity, timeline and marketing budget all look different depending on which side of this fork you start from. Direct-to-consumer keeps the customer relationship, the pricing and the brand story entirely in your hands, and it is generally the faster route to a first sale because it does not depend on a buyer conversation landing on your timeline.

Retail brings something direct-to-consumer cannot: shelf presence, third-party credibility and a distribution reach that compounds once an account is won. It also brings a longer runway to first sale, less control over how the product is presented next to a competing set on shelf, and an inventory commitment that has to exist before a purchase order does, not after.

The two are not mutually exclusive, and most brands that succeed in the US do not choose one and permanently ignore the other. A common, lower-risk sequence proves demand direct-to-consumer first, then brings a retail buyer real repeat-purchase evidence rather than a concept alone — the same ladder logic that applies to route choice inside a single manufacturing brief, applied here to channel choice instead.

A frequent failure mode runs in either direction: a brand that stays direct-to-consumer for years after a retail account was genuinely ready to say yes, or a brand that chases a retail conversation before it has any US sales evidence to bring to the table. Neither timing failure is really about the product — both are about skipping the sequencing question this section is asking you to answer first.

A direct-to-consumer launch in the US runs on the same core mechanics as a DTC launch anywhere: a storefront, a subscription or single-purchase offer, and a content and creative cadence that needs to move faster than a retail relationship ever will. What changes is the audience's baseline expectations around checkout experience, shipping speed and the kind of storefront content that reads as credible rather than unfamiliar to a first-time US buyer.

The compliance discipline does not loosen for a digital storefront. The same label that ships on the physical pack is the one your product page reproduces in an image, and a claim that would not survive an artwork review should not survive a product-page description either — a digital-first channel is still bound by the same on-pack compliance ownership described above, not a separate, lighter standard because nothing is printed on a shelf.

Used well, direct-to-consumer is a genuine testing ground: it lets a brand validate one or two SKUs in the US market before committing to the retail conversations and inventory commitments the next section covers, at a much lower first-order cost than opening an untested retail relationship.

Content built for a European audience rarely transfers unedited: the reference points, the tone and the specific claims permitted in a product description all need a fresh review against the US destination market's requirements, not a straight copy-paste from an EU storefront with a currency symbol swapped. Budget for that review as part of the DTC launch plan, not as a correction after the first customer feedback arrives.

A US retail account is evaluating two things before a product ever reaches a shelf: whether the brand already has a credible sales story, and whether the packaging reads clearly at a glance in a crowded set. Both conversations happen well before the first unit ships, which means a retail-first US entry needs its brand story and its pack design finished earlier in the process than a direct-to-consumer launch does.

Retail timing has to respect the same production planning range as any other order: lead time is typically 5–12 weeks depending on format, packaging, the production slot available and the destination market, with the confirmed timeline set during order setup rather than promised at the buyer-conversation stage. Build the retail intake date backward from that range, not forward from a hoped-for shelf date, because a retail account rarely moves its own calendar to match a supplier's.

Packaging built for a European shelf is worth reviewing fresh for a US retail account rather than assumed to translate directly — pack count, case configuration and shelf-facing presentation expectations are frequently different enough that a straight port of EU packaging under-serves the US shelf it is meant to compete on.

Many US retail buyers also want to see or hold the physical product before committing shelf space, not just a deck. Treat that request as an extension of the sampling discipline any first production order already goes through, rather than a separate ask: the same sample round that catches a flavour or artwork issue before a production run is often the exact material a retail buyer wants in hand before saying yes.

Amazon deserves separate treatment from retail broadly, because the mechanics are genuinely different: a seller or vendor storefront and a brand registry process replace the retail buyer relationship, category placement and discovery run on the marketplace's own logic rather than a merchandising conversation with a buyer, and reviews do a large share of the persuasion work a retail shelf otherwise leaves to packaging and placement.

For a brand with an established direct-to-consumer presence, Amazon can be a genuine first US entry point: it offers discovery without needing a broker or distributor relationship first, and it reaches US buyers who research and purchase in the same session. It is not, however, equivalent to having a US retail strategy — winning a marketplace listing and winning a retail account are different growth mechanics on different timelines, and treating the first as a substitute for the second leaves an obvious channel gap.

The content and compliance discipline carries over exactly as it does across every channel above: a marketplace listing reproduces the same label and the same claims a retail pack or a DTC product page does, and the brand owner's compliance ownership over that content does not change because the storefront belongs to a marketplace rather than the brand's own site.

The alternative to treating the US as a bolt-on is to run the EU and US as one brand strategy, differentiated by channel and by destination-market detail rather than by identity. The visual brand story, the positioning and the customer relationship travel across the Atlantic largely intact; what needs deliberate adaptation is the label content, the claims permitted in each destination market, and the channel mix each market actually rewards.

Practically, this means keeping one manufacturing relationship across both destination markets rather than sourcing separately market by market. The route choice — the Ready private-label option, Make it Yours or Custom Formula R&D — and the MOQ tier attached to it do not change because the destination market changes: the Ready private-label option still starts from 1,000 units for a standard PET bottle, or 2,500 units for doypack packaging, and Make it Yours still starts from 2,500 units, regardless of whether the batch ships to an EU warehouse or a US one.

The genuine efficiency in a dual-market brand shows up here: one relationship, one ordering rhythm, and a documentation cadence you already understand from your first market, rather than two disconnected supply chains each learned from scratch. A brand that reaches for a second manufacturer purely because the destination market changed is usually solving a problem that a single relationship, briefed correctly for each market, already solves.

Given a single manufacturing relationship serving both markets, it helps to be precise about what changes in the brief and what does not. The formulation, the route chosen and the MOQ tier do not change by destination. What does change is destination-specific: an artwork review against the US market's label requirements runs alongside — not instead of — the review your EU SKU already went through, because each destination market has its own label content to check the file against.

Make it Yours is worth being specific about in a dual-market brief, because its scope is narrower than it sounds: it changes flavour, colour or shape on an existing formula, while naming and artwork continue through the same standard private-label branding process every order goes through, regardless of destination market. A US-bound Make it Yours SKU is not a separate design track — it is the same formula, personalised the same way, reviewed against a different destination market's label requirements.

Treat the US destination as its own line in the brief, not an assumption carried over from the EU line above it: state the destination market plainly, and the artwork review has something concrete to check the label against before the file is locked for print.

Once both markets are running, keep the documentation for each destination market filed separately even though the underlying formula is shared: a specification confirmation and an artwork approval are destination-specific records, and mixing an EU file with a US one is a common way a brand owner loses track of which label version actually shipped where.

The brand owner remains responsible for compliance on the finished product in whichever destination market it ships into — the claims made, the ingredient declaration, the allergen statement — even though a manufacturer supports that work with documentation and a review process. Adding the US does not shift that responsibility onto a manufacturer any more than adding a second EU country would; it adds a second destination market's requirements to check the same label discipline against.

Documentation is released by order stage rather than handed over all at once, the same sequence regardless of destination: specification confirmation, an artwork review against the destination market's requirements, and a batch-specific Certificate of Analysis issued after production and quality-control release, not before it. External testing and any additional certification scope stay project-specific and confirmed per order, never assumed automatically because a catalogue listing already exists for a different market.

A brief that states the destination market and the claims a brand wants to make on pack gives the artwork review something specific to check. A brief that leaves the US detail vague, on the assumption that whatever passed review for the EU pack will pass again, is a common way a US compliance issue surfaces after the label is printed rather than before it.

A realistic US entry timeline stacks several planning ranges rather than a single fixed date: the channel decision itself — DTC, retail, Amazon or some combination — which is entirely within the brand owner's control and worth the time it takes to get right; the artwork review against the US destination market's requirements; the 5–12 week production planning range, confirmed during order setup once the brief and formula are locked; and the channel-specific launch preparation that can run in parallel with production once artwork is approved.

Resist compressing the channel-decision stage to protect a launch date. A rushed DTC-versus-retail choice is harder to unwind later than a production date that lands a few weeks later than hoped, because a retail commitment or a marketplace listing decision made in haste is a much bigger correction than absorbing a delay inside the production planning range.

Treat every date in the calendar as the end of a range, not a fixed point, until a manufacturer has confirmed it during order setup — the same discipline that keeps a domestic launch on schedule applies with one more variable in play once a second destination market joins the plan.

Line up the content and marketing calendar against the same ranges rather than against a hoped-for date: storefront copy, retail sell sheets and marketplace listing content can all be drafted while artwork and production are underway, so the channel-specific work is ready the moment the production range closes rather than starting only once units arrive.

Before writing a US-bound brief, a brand owner should be able to answer five questions plainly, two about the brand and three about production. On the brand side: which channel comes first — direct-to-consumer, retail, Amazon or a deliberate combination — and whether the destination market is stated clearly enough for an artwork review to check a label against. On the production side: whether the MOQ and lead-time expectations for the chosen route are understood rather than assumed, who owns compliance on the finished product once it reaches a US shelf or storefront, and whether the manufacturing relationship already in place is being briefed for a second destination market, rather than replaced by a new search.

A brand owner who can answer all five before the first US-specific conversation with a manufacturer is treating US entry as the deliberate growth decision it actually is, not a reactive add-on to an existing EU or UK rollout. The manufacturing route, the MOQ tier and the production doctrine underneath a US launch are identical to the ones already familiar from the brand's first market — the decision that actually differs, and deserves the most attention, is the channel and compliance picture layered on top of them.

Get that sequencing right — channel first, destination market stated plainly, one manufacturing relationship briefed for both markets — and a US launch reads as the next deliberate chapter of an existing brand, rather than a separate business built from a blank page.